(Q85209476)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Daniel Guimarães Tiezzi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

H H A Carrara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

F F Pimentel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

H R C Marana

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

A H Macchetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

L R Mouro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

F E Zola

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

16 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

28 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

S65-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20953738%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12032-010-9711-0

15 February 2020

exact match

0 references

cites work

Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience

1 reference

12 December 2020

Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

1 reference

12 December 2020

The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy

1 reference

12 December 2020

Workup and staging of locally advanced breast cancer

1 reference

12 December 2020

Breast cancer care in developing countries

1 reference

12 December 2020

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27

1 reference

12 December 2020

Breast Cancer in Developing Countries: Challenges for Multidisciplinary Care

1 reference

12 December 2020

Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy

1 reference

12 December 2020

Breast conserving surgery after neoadjuvant therapy for large primary breast cancer

1 reference

12 December 2020

Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study

1 reference

12 December 2020

Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.

1 reference

12 December 2020

Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection.

1 reference

12 December 2020

Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study

1 reference

12 December 2020

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

12 December 2020

Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer

1 reference

12 December 2020

Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy

1 reference

12 December 2020

Sentinel node biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer.

1 reference

12 December 2020

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

1 reference

12 December 2020

Breast-conserving therapy after neoadjuvant chemotherapy: long-term results

1 reference

12 December 2020

Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14

1 reference

12 December 2020